Location History:
- Maryland Heights, MO (US) (2006)
- Chesterfield, MO (US) (2006 - 2009)
- Lexington, MA (US) (2016 - 2022)
Company Filing History:
18 out of 4,455 
3 out of 4 
2 out of 220 
Years Active: 2006-2024
Title: Li Huang Xing: Innovator in the Field of Pharmaceuticals
Introduction:
In the dynamic world of pharmaceutical research and development, individuals like Li Huang Xing emerge as key contributors. With an impressive collection of patents and a successful career in esteemed organizations, Xing has left a lasting impact on the industry. This article will shed light on his latest patents, career highlights, and notable collaborations.
Latest Patents:
Li Huang Xing has a remarkable track record, having obtained a total of 23 patents throughout his career. Two of his most recent patents are worth highlighting:
1. Pyrazolo[1,5-a]pyrazin-4-yl derivatives: This patent presents a method for treating psoriasis, a chronic autoimmune skin condition. The compound described in the patent is administered in a therapeutically effective amount to patients afflicted by psoriasis. This breakthrough offers potential new treatment options for individuals suffering from this condition.
2. Pyrazolo[1,5-A]pyrazin-4-yl and related derivatives: In this patent, Xing and his team developed compounds that function as Janus Kinase (JAK) inhibitors. The patent describes the structural makeup of the compounds and their application as potential therapeutic agents. It also explores potential combinations of these compounds with other therapeutic agents. This innovation has the potential to revolutionize the treatment of various diseases by targeting the JAK pathway.
Career Highlights:
Li Huang Xing has made notable contributions to the pharmaceutical industry throughout his career. His dedication and expertise have led him to work with prestigious companies such as Pfizer Corporation and Acurx Pharmaceuticals, LLC. These organizations provide fertile grounds for innovation, where Xing's insights have been instrumental in advancing research and development efforts.
Collaborations:
Collaborations often serve as catalysts for innovation, and Xing has had the opportunity to work with some outstanding colleagues. Liying Zhang and Andrew Fensome are two notable individuals who have collaborated with him on various projects. Their combined expertise and efforts have undoubtedly contributed to the success of Xing's patents and research endeavors.
Conclusion:
Li Huang Xing stands as an exemplary innovator in the field of pharmaceutical research and development. With 23 patents to his name, including groundbreaking technologies for treating psoriasis and developing JAK inhibitors, his contributions have the potential to improve the lives of countless individuals. Through collaborations with esteemed companies like Pfizer Corporation and Acurx Pharmaceuticals, LLC, Xing continues to push boundaries in the search for new and effective treatments. We eagerly anticipate his future endeavors and the impact they will have on the industry.